About Team Argonaut

Argonaut provides contract manufacturing in the life science and biotech arena. We come with a broad range of industry skills from Thermo Fisher Scientific, Ion Torrent, Life Technologies, Althea, Applied Biosystems, Affymetrix, Allergan Pharmaceuticals and more.

Our team has one goal; support yours. You can’t tell much about a person in a few sentences, but our backgrounds here might give you a sense of our experiences.

Meet The Argonaut Leadership Team

CEO / Board Member
Business Development / VP
VP of Operations
Principal Scientist and Technology Transfer Expert
Director of Quality Control
Director of Quality

Argonaut is Backed by Telegraph Hill Partners

Alex Herzick
Board Member
Before joining THP, Alex worked at Genzyme Corporation in the Oncology / Multiple Sclerosis Business Development Group, where he sourced, evaluated, and executed strategic M&A and licensing biopharma transactions. Prior to Genzyme, he worked as a portfolio manager at BlueMountain Capital Management, and as an investment banking analyst at Bank of America Securities.
Wayne Woodward
CEO / Board Member
With 28 years of management experience in operations, supply chain and general management, Wayne’s primary focus (in three different industries) has been on building global operations capabilities with particular emphasis on working with external manufacturing services companies. Wayne most recently worked at Thermo Fisher/Life Technologies through its Ion Torrent acquisition. He previously worked at Affymetrix, Electroglas and Ridge Technologies. Wayne began his career in manufacturing at Sun Microsystems. Wayne focuses intensely on execution and detail, which is why he also bottles his own wine.
Deval Lashkari, Ph.D.
Board Member
Deval Lashkari has worked in the life sciences area since 1988 developing and commercializing novel technologies and is a founding partner at Telegraph Hill Partners (THP). He gained corporate and business development experience through senior management positions in a number of life science companies. He was a founding Research Director at Synteni, which was acquired by Incyte Genomics, where he became Director of Product Development. He also worked with Operon Technologies (acquired by Qiagen), and Genometrix.
Paul Grossman, Ph.D.
Board Member
Before joining THP, Paul Grossman was Head of Strategy and Corporate Development for Life Technologies, holding a similar position at Invitrogen Corporation prior to the merger with Applied Biosystems. Paul has held a variety of leadership and executive roles in R&D, Legal and Corporate Development teams, including spearheading the acquisition or divestment of more than 25 businesses
Rick Hancock
Board Chairman
With 34 years of life sciences experience in senior management, R&D, operations, and quality, Rick was most recently the CEO of Althea Technologies Inc. Prior to Althea Technologies he was the senior director of operations at The Immune Response Corporation. Rick has significant experience in cGMP manufacturing, regulatory affairs, scale up, operational protocols, and team management. He also worked at Hybritech as a quality control analyst, research associate, and laboratory supervisor.